I was excited about the prospect of starting a different DMD. My neuro suggested I try Gilenya, last fall. Had all of the lab tests done, as well as an EKG and an eye exam. Too many infections during the fall semester made us hold off. My neuro even had me have blood work done to check out my immune system.
Finally, the decision was made to go ahead and try to get me in the process of starting Gilenya. All that was needed was for my insurance to approve it. From what I understood, it was about the same cost as Copaxone, so I didn't expect any problems. Silly me!
At the same time that they were giving me a hard tim about switching to a twice daily dose of Provigil (had also decided toing fwer go back on that), I was excited to get a welcome letter and package from Novartis about Gilenya. It said I was still in the insurance approval stage.
I was surprised, after that to receive a letter from my insurance company denying it. My neuro's office told me they would appeal. The appeal was also denied. Their reasons? First, they claim that I have to try 2 different injectable DMDs before being allowed to take an oral type. Why?? If it has a record of patients having fewer flares, than injectiond
Finally, the decision was made to go ahead and try to get me in the process of starting Gilenya. All that was needed was for my insurance to approve it. From what I understood, it was about the same cost as Copaxone, so I didn't expect any problems. Silly me!
At the same time that they were giving me a hard tim about switching to a twice daily dose of Provigil (had also decided toing fwer go back on that), I was excited to get a welcome letter and package from Novartis about Gilenya. It said I was still in the insurance approval stage.
I was surprised, after that to receive a letter from my insurance company denying it. My neuro's office told me they would appeal. The appeal was also denied. Their reasons? First, they claim that I have to try 2 different injectable DMDs before being allowed to take an oral type. Why?? If it has a record of patients having fewer flares, than injectiond
Comment